RU2011134040A - Способы диагностики и лечения дисфагии - Google Patents
Способы диагностики и лечения дисфагии Download PDFInfo
- Publication number
- RU2011134040A RU2011134040A RU2011134040/14A RU2011134040A RU2011134040A RU 2011134040 A RU2011134040 A RU 2011134040A RU 2011134040/14 A RU2011134040/14 A RU 2011134040/14A RU 2011134040 A RU2011134040 A RU 2011134040A RU 2011134040 A RU2011134040 A RU 2011134040A
- Authority
- RU
- Russia
- Prior art keywords
- patient
- dysphagia
- treatment
- composition
- product
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract 22
- 238000003745 diagnosis Methods 0.000 title claims abstract 6
- 208000019505 Deglutition disease Diseases 0.000 claims abstract 39
- 230000036541 health Effects 0.000 claims abstract 11
- 238000012216 screening Methods 0.000 claims abstract 9
- 230000004044 response Effects 0.000 claims abstract 6
- 208000024891 symptom Diseases 0.000 claims abstract 5
- 210000002409 epiglottis Anatomy 0.000 claims abstract 4
- 210000003300 oropharynx Anatomy 0.000 claims abstract 4
- 230000002159 abnormal effect Effects 0.000 claims abstract 2
- 210000001983 hard palate Anatomy 0.000 claims abstract 2
- 201000000615 hard palate cancer Diseases 0.000 claims abstract 2
- 230000007659 motor function Effects 0.000 claims abstract 2
- 238000002360 preparation method Methods 0.000 claims abstract 2
- 210000001584 soft palate Anatomy 0.000 claims abstract 2
- 238000012360 testing method Methods 0.000 claims abstract 2
- 239000000203 mixture Substances 0.000 claims 15
- 238000000554 physical therapy Methods 0.000 claims 6
- 210000003238 esophagus Anatomy 0.000 claims 4
- 235000013305 food Nutrition 0.000 claims 3
- 230000001195 anabolic effect Effects 0.000 claims 2
- 230000006999 cognitive decline Effects 0.000 claims 2
- 208000010877 cognitive disease Diseases 0.000 claims 2
- 230000003920 cognitive function Effects 0.000 claims 2
- 230000007423 decrease Effects 0.000 claims 2
- 230000037213 diet Effects 0.000 claims 2
- 235000005911 diet Nutrition 0.000 claims 2
- 230000036039 immunity Effects 0.000 claims 2
- 238000009434 installation Methods 0.000 claims 2
- 210000002200 mouth mucosa Anatomy 0.000 claims 2
- 230000009467 reduction Effects 0.000 claims 2
- 230000011514 reflex Effects 0.000 claims 2
- 238000010992 reflux Methods 0.000 claims 2
- 230000009747 swallowing Effects 0.000 claims 2
- 239000005541 ACE inhibitor Substances 0.000 claims 1
- 206010039424 Salivary hypersecretion Diseases 0.000 claims 1
- 102100029613 Transient receptor potential cation channel subfamily V member 1 Human genes 0.000 claims 1
- 108050004388 Transient receptor potential cation channel subfamily V member 1 Proteins 0.000 claims 1
- 239000000556 agonist Substances 0.000 claims 1
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- 238000004590 computer program Methods 0.000 claims 1
- 238000002405 diagnostic procedure Methods 0.000 claims 1
- -1 flavorings Substances 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 238000012986 modification Methods 0.000 claims 1
- 230000004048 modification Effects 0.000 claims 1
- 238000012544 monitoring process Methods 0.000 claims 1
- 239000006041 probiotic Substances 0.000 claims 1
- 235000018291 probiotics Nutrition 0.000 claims 1
- 208000026451 salivation Diseases 0.000 claims 1
- 239000000021 stimulant Substances 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 239000002562 thickening agent Substances 0.000 claims 1
- 238000002604 ultrasonography Methods 0.000 claims 1
- 240000008042 Zea mays Species 0.000 abstract 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 abstract 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 abstract 1
- 235000005822 corn Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/212—Starch; Modified starch; Starch derivatives, e.g. esters or ethers
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/238—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from seeds, e.g. locust bean gum or guar gum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14539—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring pH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/22—Ergometry; Measuring muscular strength or the force of a muscular blow
- A61B5/224—Measuring muscular strength
- A61B5/228—Measuring muscular strength of masticatory organs, e.g. detecting dental force
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
- A61B5/414—Evaluating particular organs or parts of the immune or lymphatic systems
- A61B5/415—Evaluating particular organs or parts of the immune or lymphatic systems the glands, e.g. tonsils, adenoids or thymus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
- A61B5/414—Evaluating particular organs or parts of the immune or lymphatic systems
- A61B5/418—Evaluating particular organs or parts of the immune or lymphatic systems lymph vessels, ducts or nodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/42—Detecting, measuring or recording for evaluating the gastrointestinal, the endocrine or the exocrine systems
- A61B5/4205—Evaluating swallowing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/20—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for electronic clinical trials or questionnaires
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H15/00—ICT specially adapted for medical reports, e.g. generation or transmission thereof
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2505/00—Evaluating, monitoring or diagnosing in the context of a particular type of medical care
- A61B2505/03—Intensive care
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2505/00—Evaluating, monitoring or diagnosing in the context of a particular type of medical care
- A61B2505/07—Home care
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2505/00—Evaluating, monitoring or diagnosing in the context of a particular type of medical care
- A61B2505/09—Rehabilitation or training
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S128/00—Surgery
- Y10S128/92—Computer assisted medical diagnostics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S128/00—Surgery
- Y10S128/92—Computer assisted medical diagnostics
- Y10S128/921—Diet management
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S128/00—Surgery
- Y10S128/92—Computer assisted medical diagnostics
- Y10S128/922—Computer assisted medical diagnostics including image analysis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S128/00—Surgery
- Y10S128/92—Computer assisted medical diagnostics
- Y10S128/923—Computer assisted medical diagnostics by comparison of patient data to other data
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S128/00—Surgery
- Y10S128/92—Computer assisted medical diagnostics
- Y10S128/923—Computer assisted medical diagnostics by comparison of patient data to other data
- Y10S128/924—Computer assisted medical diagnostics by comparison of patient data to other data using artificial intelligence
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Medical Informatics (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biophysics (AREA)
- Surgery (AREA)
- Molecular Biology (AREA)
- Polymers & Plastics (AREA)
- Primary Health Care (AREA)
- Epidemiology (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Dispersion Chemistry (AREA)
- Immunology (AREA)
- Vascular Medicine (AREA)
- Medicinal Chemistry (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Databases & Information Systems (AREA)
- Data Mining & Analysis (AREA)
- Physical Education & Sports Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Physiology (AREA)
- Organic Chemistry (AREA)
- Optics & Photonics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Husbandry (AREA)
- Birds (AREA)
- Zoology (AREA)
Abstract
1. Способ лечения пациентов от дисфагии, который включает:a) скрининг пациентов на симптомы дисфагии;b) диагностику дисфагии;c) выбор надлежащего продукта для лечения дисфагии, если у пациента превышен порог по симптомам дисфагии; иd) предоставление пациенту инструкций по приготовлению продукта для лечения дисфагии.2. Способ по п.1, в котором стадия скрининга включает получение ответов пациента на вопросы из анкеты по скринингу дисфагии и оценку анкеты на основании ответов пациента.3. Способ по п.1, в котором стадия диагностики включает:a) получение ответов пациента на вопросы из анкеты, включающей последнюю информацию относительно параметров дисфагии, установленных при опросе медработников, наблюдаемые параметры и заявленные самим пациентом параметры;b) определение балльной оценки для анкеты на основании ответов пациента иc) идентификацию и классификацию дисфагии, если у пациента превышена пороговая оценка.4. Способ по п.1, в котором выбор надлежащего лечения дисфагии основывается на диагностике и классификации пациента на основании по меньшей мере одного из следующего:i) измерения силы, прилагаемой языком пациента на мягкое и/или твердое небо;ii) определения полноты закрывания дыхательных путей и надгортанника у пациента;iii) определения правильности времени закрывания дыхательных путей и надгортанника у пациента;iv) проведения теста «кукурузные хлопья» у пациента;v) круглосуточного мониторинга трахеального значения pH у пациента;vi) проведения УЗИ у пациента для выявления аномальной моторной функции ротоглотки;vii) использования прибора для проверки приготовления продукта; иviii) проведения оценки гигиены ротово�
Claims (22)
1. Способ лечения пациентов от дисфагии, который включает:
a) скрининг пациентов на симптомы дисфагии;
b) диагностику дисфагии;
c) выбор надлежащего продукта для лечения дисфагии, если у пациента превышен порог по симптомам дисфагии; и
d) предоставление пациенту инструкций по приготовлению продукта для лечения дисфагии.
2. Способ по п.1, в котором стадия скрининга включает получение ответов пациента на вопросы из анкеты по скринингу дисфагии и оценку анкеты на основании ответов пациента.
3. Способ по п.1, в котором стадия диагностики включает:
a) получение ответов пациента на вопросы из анкеты, включающей последнюю информацию относительно параметров дисфагии, установленных при опросе медработников, наблюдаемые параметры и заявленные самим пациентом параметры;
b) определение балльной оценки для анкеты на основании ответов пациента и
c) идентификацию и классификацию дисфагии, если у пациента превышена пороговая оценка.
4. Способ по п.1, в котором выбор надлежащего лечения дисфагии основывается на диагностике и классификации пациента на основании по меньшей мере одного из следующего:
i) измерения силы, прилагаемой языком пациента на мягкое и/или твердое небо;
ii) определения полноты закрывания дыхательных путей и надгортанника у пациента;
iii) определения правильности времени закрывания дыхательных путей и надгортанника у пациента;
iv) проведения теста «кукурузные хлопья» у пациента;
v) круглосуточного мониторинга трахеального значения pH у пациента;
vi) проведения УЗИ у пациента для выявления аномальной моторной функции ротоглотки;
vii) использования прибора для проверки приготовления продукта; и
viii) проведения оценки гигиены ротовой полости у пациента.
5. Способ по п.1, в котором продукт для лечения дисфагии включает по меньшей мере одно из следующего:
i) композицию, которая усиливает или восстанавливает иммунитет у пациента;
ii) композицию, которая запускает, усиливает или восстанавливает глотательный рефлекс у пациента;
iii) композицию, которая усиливает или восстанавливает слизистую полости рта у пациента;
iv) композицию, которая поддерживает когнитивную функциональность пациента;
v) композицию, которая предотвращает когнитивный спад у пациента;
vi) композицию, которая улучшает безопасное прохождение комка пищи или напитка через ротоглотку и пищевод;
vii) композицию, которая уменьшает рефлюкс из пищевода.
6. Способ по п.1, в котором продукт для лечения дисфагии включает компонент, выбранный из группы, состоящей из пробиотиков, агонистов ваниллоидного рецептора-1, ингибиторов ангиотензин-конвертирующего фермента, основных носителей вкуса, стимуляторов тройничного нерва, ароматизаторов, веществ, вызывающих слюноотделение, загустителей, шипучих композиций и их комбинаций.
7. Способ по п.1, в котором стадии скрининга, диагностики, классификации, выбора и осуществления лечения представляют алгоритм, исполняемый в компьютерной программе.
8. Способ по п.1, в котором лечение дисфагии пациента снижает расходы на здравоохранение, связанные со скрытой дисфагией у пациента.
9. Способ по п.1, в котором инструкции по приготовлению продукта для пациента включают следование модификациям пищи в соответствии с особенностями лечения дисфагии.
10. Способ по п.1, в котором продукт для лечения дисфагии представляет собой курс физиотерапии на основании дисфагии пациента.
11. Способ по п.10, в котором курс физиотерапии включает по меньшей мере одно из следующего:
i) проведение установки определенного положения тела во время и после еды и
ii) выполнение реабилитационных упражнений.
12. Способ по п.10, в котором курс физиотерапии идет в паре с режимом анаболического питания.
13. Способ по п.1, дополнительно включающий предоставление пациенту продуктов и услуг, способствующих реабилитации пациента в медицинском центре.
14. Набор для предоставления лечения пациентам с дисфагией, который включает:
i) инструмент скрининга, которым проводится скрининг пациентов на дисфагию;
ii) диагностический тест, которым проводится классификация дисфагии, если у пациента превышен порог по симптомам дисфагии;
iii) рекомендуемый курс лечения дисфагии на основании дисфагии пациента и
iv) инструкции для осуществления лечения дисфагии.
15. Набор по п.14, в котором лечение дисфагии включает по меньшей мере одно из следующего:
i) композицию, которая усиливает или восстанавливает иммунитет у пациента;
ii) композицию, которая запускает, усиливает или восстанавливает глотательный рефлекс у пациента;
iii) композицию, которая усиливает или восстанавливает слизистую полости рта у пациента;
iv) композицию, которая поддерживает когнитивную функциональность пациента;
v) композицию, которая предотвращает когнитивный спад у пациента;
vi) композицию, которая улучшает безопасное прохождение комка пищи или напитка через ротоглотку и пищевод;
vii) композицию, которая уменьшает рефлюкс из пищевода.
16. Набор по п.14, в котором лечение дисфагии у пациента представляет собой курс физиотерапии на основании дисфагии пациента.
17. Набор по п.16, в котором курс физиотерапии включает по меньшей мере одно из следующего:
i) выполнение установки определенного положения тела во время и после еды и
ii) выполнение реабилитационных упражнений.
18. Набор по п.16, в котором курс физиотерапии идет в паре с режимом анаболического питания.
19. Способ снижения расходов на здравоохранение, связанных с дисфагией, который включает применение способа, выбранного из группы, состоящей из способов, приведенных в пп.1-13.
20. Способ снижения расходов на здравоохранение по п.19, в котором снижение расходов на здравоохранение обусловлено уменьшением числа случаев аспирации.
21. Способ снижения расходов на здравоохранение по п.19, в котором снижение расходов на здравоохранение обусловлено лечением инфекций и/или спирали ухудшения здоровья, вызванных дисфагией.
22. Способ снижения расходов на здравоохранение по п.19, в котором снижение расходов на здравоохранение обусловлено меньшим использованием больниц, амбулаторных учреждений или заведений для квалифицированного ухода.
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12069009P | 2009-01-15 | 2009-01-15 | |
US61/120,690 | 2009-01-15 | ||
US24078909P | 2009-09-09 | 2009-09-09 | |
US61/240,789 | 2009-09-09 | ||
US25823209P | 2009-11-05 | 2009-11-05 | |
US61/258,232 | 2009-11-05 | ||
PCT/US2009/066972 WO2010082986A1 (en) | 2009-01-15 | 2009-12-07 | Methods of diagnosing and treating dysphagia |
Publications (1)
Publication Number | Publication Date |
---|---|
RU2011134040A true RU2011134040A (ru) | 2013-02-20 |
Family
ID=41682298
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2011134040/14A RU2011134040A (ru) | 2009-01-15 | 2009-12-07 | Способы диагностики и лечения дисфагии |
Country Status (13)
Country | Link |
---|---|
US (1) | US8696568B2 (ru) |
EP (1) | EP2381835A1 (ru) |
JP (2) | JP2012515045A (ru) |
CN (1) | CN102348407B (ru) |
AU (1) | AU2009337091B2 (ru) |
BR (1) | BRPI0924069A2 (ru) |
CA (1) | CA2748986C (ru) |
HK (1) | HK1162292A1 (ru) |
MX (1) | MX2011007578A (ru) |
RU (1) | RU2011134040A (ru) |
SG (1) | SG172467A1 (ru) |
WO (1) | WO2010082986A1 (ru) |
ZA (1) | ZA201105933B (ru) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11684571B2 (en) | 2016-08-18 | 2023-06-27 | Ellodi Pharmaceuticals, L.P. | Methods of treating eosinophilic esophagitis |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8936471B2 (en) * | 2009-02-15 | 2015-01-20 | Cheryl L. Evans | Flow rate measuring device |
US8753124B2 (en) * | 2009-02-15 | 2014-06-17 | Cheryl Lynn Evans | Method and apparatus for prescribing and preparing a reproducible and customized dysphagia diet |
US9858831B2 (en) * | 2009-02-15 | 2018-01-02 | Cheryl L. Evans | Method for determining and prescribing quantifiable and customized diet for patient suffering from dysphagia |
US10854105B2 (en) * | 2009-02-15 | 2020-12-01 | Cheryl L. Evans | Method for objectively reproducing a dysphagia diet |
US10143404B2 (en) * | 2010-11-17 | 2018-12-04 | University Of Florida Research Foundation, Inc. | Systems and methods for automatically determining patient swallow frequency |
CN102551685B (zh) * | 2010-12-30 | 2015-04-01 | 世意法(北京)半导体研发有限责任公司 | 对象监视器 |
US9687191B2 (en) * | 2011-01-18 | 2017-06-27 | Holland Bloorview Kids Rehabilitation Hospital | Method and device for swallowing impairment detection |
EP2667777B1 (en) * | 2011-01-28 | 2016-08-10 | Nestec S.A. | Apparatuses for diagnosing swallowing dysfunction |
EP2766866A4 (en) * | 2011-10-14 | 2015-06-17 | Univ Pennsylvania | ASSISTANCE SYSTEM FOR RELEASE DECISIONS FOR POSTAL CARE SERVICES |
EP2790531B1 (en) * | 2011-12-15 | 2022-01-19 | Société des Produits Nestlé S.A. | Cohesive thin liquids to promote safe swallowing in dysphagic patients |
BR112014026344A2 (pt) * | 2012-04-27 | 2017-06-27 | Nestec Sa | métodos para aumentar eficiência do ato de engolir |
CN103426350B (zh) * | 2012-05-25 | 2017-02-08 | 天津天堰科技股份有限公司 | 一种模拟吞咽的装置 |
JP6244357B2 (ja) * | 2012-06-19 | 2017-12-06 | ネステク ソシエテ アノニム | 嚥下障害の検出および/または診断を行うための機器 |
US9107385B2 (en) | 2013-04-15 | 2015-08-18 | The Curators Of The University Of Missouri | Animal kennel for scientific examination |
WO2015152147A1 (ja) * | 2014-03-31 | 2015-10-08 | シャープ株式会社 | 調理機器 |
CA2938789A1 (en) * | 2014-04-09 | 2015-10-15 | Nestec S.A. | Technique for determining a swallowing deficiency |
CA2957559C (en) | 2014-08-11 | 2023-09-12 | University Of Southern California | Swallow exerciser |
CA2954577A1 (en) * | 2014-09-04 | 2016-03-10 | Nestec S.A. | Method for monitoring swallowing |
US10176301B2 (en) | 2014-09-11 | 2019-01-08 | Meritage Pharma, Inc. | Systems, methods, and software for providing a patient-reported outcome measure of dysphagia patients with eosinophilic esophagitis |
US11534400B2 (en) * | 2016-06-03 | 2022-12-27 | Societe Des Produits Nestle S.A. | Compositions and methods for improving hydration of individuals having dysphagia |
JP6901724B2 (ja) * | 2017-04-13 | 2021-07-14 | 剛志 長谷 | プログラム、及び、情報表示装置 |
CN110536636A (zh) * | 2017-07-28 | 2019-12-03 | 梅尔廷Mmi株式会社 | 用于识别产生肌电信号的动作的系统、方法以及程序 |
WO2019225242A1 (ja) * | 2018-05-23 | 2019-11-28 | パナソニックIpマネジメント株式会社 | 摂食嚥下機能評価方法、プログラム、摂食嚥下機能評価装置および摂食嚥下機能評価システム |
EP3598933A1 (en) * | 2018-06-26 | 2020-01-29 | Koninklijke Philips N.V. | Monitoring swallowing in a subject |
IT201800009675A1 (it) * | 2018-10-22 | 2020-04-22 | Lb Lyopharm Srl | Metodo e kit per valutare la capacita’ di deglutizione |
CN109666601B (zh) * | 2018-12-03 | 2022-01-18 | 杭州娃哈哈科技有限公司 | 一株具有抑菌特性的植物乳杆菌及其在腹泻预防中的应用 |
KR102094828B1 (ko) * | 2019-09-24 | 2020-04-27 | 가톨릭대학교 산학협력단 | 비디오투시 연하검사 판독 장치 및 방법 |
JP2023533672A (ja) * | 2020-07-15 | 2023-08-04 | ソシエテ・デ・プロデュイ・ネスレ・エス・アー | 嚥下の安全性及び効率を促進するための組成物 |
KR102539321B1 (ko) * | 2020-10-14 | 2023-06-05 | 연세대학교 산학협력단 | 삼킴 모니터링 및 훈련을 위한 방법, 디바이스 및 기록매체 |
CN113435070B (zh) * | 2021-08-27 | 2021-11-09 | 成都大学 | 一种剪切增稠液的流变性能预测方法及系统 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5976084A (en) * | 1997-10-24 | 1999-11-02 | Regents Of The University Of Minnesota | Standardized test for dysphagia |
US7593952B2 (en) * | 1999-04-09 | 2009-09-22 | Soll Andrew H | Enhanced medical treatment system |
US6461589B2 (en) * | 1999-08-27 | 2002-10-08 | Wisconsin Alumni Research Foundation | Standardized compositions which facilitate swallowing in dysphagic subjects |
US6592863B2 (en) * | 2000-08-22 | 2003-07-15 | Nestec S.A. | Nutritional composition |
US7638150B2 (en) * | 2002-08-02 | 2009-12-29 | Simply Thick Llp | Process for preparing concentrate thickener compositions |
EP2260723A3 (en) * | 2001-08-02 | 2013-01-02 | Simply Thick LLC | Process for Preparing Concentrate Thickener Compositions |
JP2003111748A (ja) | 2001-10-04 | 2003-04-15 | Nippon Riko Igaku Kenkyusho:Kk | 嚥下音採取装置 |
JP2006516995A (ja) * | 2003-01-31 | 2006-07-13 | シンプリー スィック,リミティド ライアビリティー カンパニー | 嚥下障害のための改良された増粘飲料 |
WO2006054886A1 (en) * | 2004-11-18 | 2006-05-26 | N.V. Nutricia | Thickener composition for dysphagia patients |
CN2863149Y (zh) * | 2005-12-07 | 2007-01-31 | 张希忠 | 吞咽困难治疗棒 |
US7660636B2 (en) * | 2006-01-04 | 2010-02-09 | Accelerated Care Plus Corp. | Electrical stimulation device and method for the treatment of dysphagia |
JP2008000005A (ja) * | 2006-06-20 | 2008-01-10 | Shizuoka Prefecture | 嚥下障害改善剤および嚥下障害改善食品 |
WO2008013536A2 (en) * | 2006-07-26 | 2008-01-31 | Sensient Flavors Inc. | Food products comprising probiotic microorganisms and methods of preparation |
JP2008094743A (ja) * | 2006-10-10 | 2008-04-24 | Tohoku Techno Arch Co Ltd | 摂食・嚥下改善食品 |
US20100311686A1 (en) * | 2009-06-03 | 2010-12-09 | Kasper Lloyd H | Nutraceutical composition and methods for preventing or treating multiple sclerosis |
-
2009
- 2009-12-07 BR BRPI0924069A patent/BRPI0924069A2/pt not_active Application Discontinuation
- 2009-12-07 SG SG2011049160A patent/SG172467A1/en unknown
- 2009-12-07 JP JP2011546246A patent/JP2012515045A/ja active Pending
- 2009-12-07 EP EP09795609A patent/EP2381835A1/en not_active Withdrawn
- 2009-12-07 MX MX2011007578A patent/MX2011007578A/es unknown
- 2009-12-07 CN CN2009801580321A patent/CN102348407B/zh active Active
- 2009-12-07 US US13/144,605 patent/US8696568B2/en active Active
- 2009-12-07 AU AU2009337091A patent/AU2009337091B2/en active Active
- 2009-12-07 WO PCT/US2009/066972 patent/WO2010082986A1/en active Application Filing
- 2009-12-07 RU RU2011134040/14A patent/RU2011134040A/ru not_active Application Discontinuation
- 2009-12-07 CA CA2748986A patent/CA2748986C/en active Active
-
2011
- 2011-08-12 ZA ZA2011/05933A patent/ZA201105933B/en unknown
-
2012
- 2012-04-03 HK HK12103349.8A patent/HK1162292A1/xx not_active IP Right Cessation
-
2014
- 2014-07-28 JP JP2014152988A patent/JP2014224133A/ja active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11684571B2 (en) | 2016-08-18 | 2023-06-27 | Ellodi Pharmaceuticals, L.P. | Methods of treating eosinophilic esophagitis |
US11896710B2 (en) | 2016-08-18 | 2024-02-13 | Ellodi Pharmaceuticals, L.P. | Methods of treating eosinophilic esophagitis |
Also Published As
Publication number | Publication date |
---|---|
CN102348407A (zh) | 2012-02-08 |
HK1162292A1 (en) | 2012-08-31 |
AU2009337091B2 (en) | 2014-01-23 |
MX2011007578A (es) | 2011-08-04 |
SG172467A1 (en) | 2011-07-28 |
AU2009337091A1 (en) | 2011-08-04 |
CA2748986C (en) | 2019-12-24 |
WO2010082986A1 (en) | 2010-07-22 |
JP2014224133A (ja) | 2014-12-04 |
ZA201105933B (en) | 2013-01-30 |
BRPI0924069A2 (pt) | 2017-03-28 |
EP2381835A1 (en) | 2011-11-02 |
JP2012515045A (ja) | 2012-07-05 |
US20120046641A1 (en) | 2012-02-23 |
US8696568B2 (en) | 2014-04-15 |
CA2748986A1 (en) | 2010-07-22 |
CN102348407B (zh) | 2013-12-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2011134040A (ru) | Способы диагностики и лечения дисфагии | |
Dziewas et al. | Diagnosis and treatment of neurogenic dysphagia–S1 guideline of the German Society of Neurology | |
Baijens et al. | European Society for Swallowing Disorders–European Union Geriatric Medicine Society white paper: oropharyngeal dysphagia as a geriatric syndrome | |
Murakami et al. | Relationship between swallowing function and the skeletal muscle mass of older adults requiring long‐term care | |
Mizuno et al. | Neonatal feeding performance as a predictor of neurodevelopmental outcome at 18 months | |
JP2012515045A5 (ru) | ||
De Oliveira Lira Ortega et al. | Assessment scale of the oral motor performance of children and adolescents with neurological damages | |
McCullough et al. | Clinical evaluation of patients with dysphagia: Importance of history taking and physical exam | |
Molfenter et al. | The swallowing profile of healthy aging adults: comparing noninvasive swallow tests to videofluoroscopic measures of safety and efficiency | |
CN103338700A (zh) | 用于诊断吞咽障碍的设备和方法 | |
Miller et al. | Dysphagia: implications for older people | |
Karacayli et al. | The effects of chronic pain on oral health related quality of life in patients with anterior disc displacement with reduction. | |
Ferris et al. | Pressure-flow analysis for the assessment of pediatric oropharyngeal dysphagia | |
Ohta et al. | Oral function and nutritional status in non‐acute hospitalised elders | |
Hägglund et al. | The Test of Masticating and Swallowing Solids (TOMASS): Normative data for two crackers available in the Scandinavian and international markets | |
Riquelme et al. | Feeding/swallowing disorders: Maintaining quality of life in persons with intellectual disability | |
Śledzik¹ et al. | Dysphagia in neurological disorders | |
Krasnodębska et al. | Diagnosis in muscle tension dysphagia | |
Hoang et al. | Orofacial dysfunction screening examinations in children with sleep-disordered breathing symptoms. | |
Akram et al. | Attitude and knowledge of family medicine practitioners towards the association between periodontal disease and obesity | |
Donohue | Proactive Dysphagia Management of Patients with Neurodegenerative Diseases: Early Identification and Intervention | |
Kooi-van Es et al. | 8th ESSD Congress, Dublin 2018 | |
Izumi et al. | Posterior teeth occlusion is related independently to onset of fever in residents of aged person welfare facility: prospective cohort study | |
Everton | Post-stroke dysphagia: clinical and radiological outcomes and efficacy | |
Riera-Punet | Alterations in the masticatory system in patients with amyotrophic lateral sclerosis and its management with an oral appliance |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20140715 |